DVA – davita inc. (US:NASDAQ)

News

DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at Barclays PLC from $150.00 to $164.00. They now have an "equal weight" rating on the stock.
DaVita Inc. 3rd Quarter 2024 Results
DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com